To assess the sensitivity of different subtypes of B-cell lymphoma to BET inhibition, murine Eμ-myc and human B-cell lymphomas were exposed to increasing concentrations of I-BET762 over time as indicated (Supplementary Figure S1). This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.